These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1964677)

  • 1. 4'-EPI-doxorubicin in advanced lung cancer. A phase II trial.
    Giaccone G; Donadio M; Bonardi G; Iberti V; Calciati A
    Invest New Drugs; 1990 Nov; 8(4):393-6. PubMed ID: 1964677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Hansen HH; Hansen M; Renard J; Rozencweig M
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):495-9. PubMed ID: 6327315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of high-dose epirubicin in non-small cell lung cancer.
    Wils J; Utama I; Sala L; Smeets J; Riva A
    Eur J Cancer; 1990; 26(11-12):1140-1. PubMed ID: 1963545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epirubicin in previously untreated patients with small cell lung cancer: a phase II study by the EORTC Lung Cancer Cooperative Group.
    Quoix EA; Giaccone G; Jassem J; Karnicka H; Wiatr E; Cortes-Funes H; Roozendaal KJ; Kirkpatrick A; Evrard D; van Zandwijk N
    Eur J Cancer; 1992; 28A(10):1667-70. PubMed ID: 1327019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of high dose epirubicin in unresectable non small cell lung cancer.
    Smit EF; Berendsen HH; Piers DA; Smeets J; Riva A; Postmus PE
    Br J Cancer; 1992 Mar; 65(3):405-8. PubMed ID: 1313691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin: a phase II study in recurrent small-cell lung cancer.
    Rosenthal M; Kefford R; Raghavan D; Stuart-Harris R
    Cancer Chemother Pharmacol; 1991; 28(3):220-2. PubMed ID: 1713130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG).
    Eckhardt S; Kolaric K; Vukas D; Kánitz E; Schoket Z; Jassem J; Vuletic L; Jelic S; Mechl Z; Koza I
    Med Oncol Tumor Pharmacother; 1990; 7(1):19-23. PubMed ID: 2160033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer.
    Feld R; Wierzbicki R; Walde PL; Shepherd FA; Evans WK; Gupta S; Shannon P; Lassus M
    J Clin Oncol; 1992 Feb; 10(2):297-303. PubMed ID: 1310105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin C and menadione for the treatment of lung cancer: a phase II trial.
    Tetef M; Margolin K; Ahn C; Akman S; Chow W; Leong L; Morgan RJ; Raschko J; Somlo G; Doroshow JH
    Invest New Drugs; 1995; 13(2):157-62. PubMed ID: 8617579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer.
    Kánitz E; Kolaric K; Jassem J; Mechl Z; Pawlicki M; Ringwald G; Rolski J; Schoket Z; Vukas D; Kaplan E
    Oncology; 1992; 49(5):327-32. PubMed ID: 1326734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
    Schütte J; Niederle N; Grunenberg B; Krischke W; Seeber S; Schmidt CG
    J Cancer Res Clin Oncol; 1984; 107(1):38-41. PubMed ID: 6583205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A phase II study of epirubicin in advanced lung cancer].
    Furuse K; Fukuoka M; Yamamoto M; Kawahara M; Tsuruta M; Kodama N; Arai R; Hayashi S; Kiyota M; Kubota K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2835-40. PubMed ID: 3019252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of high-dose epirubicin in untreated patients with small-cell lung cancer.
    Macchiarini P; Danesi R; Mariotti R; Marchetti A; Fazzi P; Bevilacqua G; Mariani M; Giuntini C; Del Tacca M; Angeletti CA
    Am J Clin Oncol; 1990 Aug; 13(4):302-7. PubMed ID: 2165738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.
    Smit EF; Piers DA; Postmus PE
    Eur J Cancer; 1992; 28A(12):1965-7. PubMed ID: 1329882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma. Polish Lung Cancer Cooperative Group.
    Jassem J; Karnicka-Młodkowska H; Drozd-Lula M; Strug A; Pilarska-Machowicz A; Michalski A; Kowal E; Moś-Antkowiak R; Zych J
    Eur J Cancer; 1992; 28(2-3):473-6. PubMed ID: 1317199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trial.
    Gasparini G; Dal Fior S; Panizzoni GA; Favretto S; Pozza F
    Am J Clin Oncol; 1991 Feb; 14(1):38-44. PubMed ID: 1987737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of high-dose epirubicin in advanced non-small cell lung cancer.
    Martoni A; Melotti B; Guaraldi M; Pannuti F
    Eur J Cancer; 1991; 27(10):1231-4. PubMed ID: 1659841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose epirubicin for untreated patients with advanced tumours: a phase I study.
    Martoni A; Melotti B; Guaraldi M; Pacciarini MA; Riva A; Pannuti F
    Eur J Cancer; 1990; 26(11-12):1137-40. PubMed ID: 1963544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
    Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.